Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.
Chun WuYanhua HuPeter SchaferSean E ConnollyRobert WongSigne Holm NielsenAnne-Christine Bay-JensenPaul EmeryYoshiya TanakaVivian P BykerkClifton O BinghamThomas Wj HuizingaRoy M FleischmannJinqi LiuPublished in: RMD open (2023)
In MTX-naive, ACPA-positive patients with early RA, baseline CTX-I predicted treatment response to abatacept+MTX but not abatacept placebo+MTX.